Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada.

BMJ Open · 2017 · PMC5588972 · PMID 28860225

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

38 Among Chinese patients, we observed generally similar mortality reductions associated with ACEi (HR=0.84, 0.69–1.03) and ARB (HR=0.64, 0.50–0.82) use, although the benefit of ACEi did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.